Due to lack of sufficient eligible subjects, no safety concerns

The purpose of this study is to identify out of up to three doses a safe and effective dose of Botulinum toxin type A for an injection into one side of the soft palate to treat snoring.

Inclusion Criteria:

• Female or male subjects aged 18-70
• Subjects suffering from snoring for at least 3 months prior to the study start and seeking for help to treat snoring
• Subjects with a peak Snoring Index [SI] ≥ 15/ hour of sleep [h] at baseline visit
• Subjects with a bed partner for at least three months prior to study start.
• Subjects who understand the nature of the study and provide written Informed Consent at screening visit.
• Subjects who understand the study procedures as well as possess the ability and willingness to abide by all procedures during the course of the study

Exclusion Criteria:

• Obese subjects (Body Mass Index ≥ 30)
• Subjects with severe obstructive sleep apnea syndrome
• Subjects with Apnea-Hypopnea Index ≥ 10 /hour of sleep and/ or Respiratory Disturbance Index ≥ 25 / hour of sleep at the baseline visit
• Subjects who have undergone any Botulinum neurotoxin treatment in the history
• Subjects with generalized disorders of muscle activity (e.g. myasthenia gravis, Lambert-Eaton syndrome)
• Acute infections of the pharynx